Skip to main content
SpringerLink
Log in

Stress-Triggered Graves’ Disease with Multiple Exacerbations in a Pregnant Woman with High Levels of Thyrotropin Receptor Antibodies and No Complicated Delivery: a Case Report

  • Medicine
  • Published:
SN Comprehensive Clinical Medicine Aims and scope Submit manuscript

Abstract

Graves’ disease (GD) is an autoimmune thyroid disease in which stimulation by thyrotropin-receptor antibodies (TRAb) causes thyroid enlargement and hyperfunction. GD is an uncommon condition during gestation, as it occurs in about 0.2% of pregnant women. The typical GD course during gestation is characterized by a progressive reduction of TRAb levels, with associated clinical improvement, but subsequent recurrence after delivery. Instead, gestational GD requires close monitoring, because if inadequately controlled with maternal TRAb levels remaining elevated, it is associated with adverse maternal, fetal, and neonatal outcomes. We describe the case of a 39-year-old woman, who was diagnosed with stress-triggered GD at 1st trimester of her pregnancy. At diagnosis, TRAb levels were very high (30.4 U/L, normal values < 1.5). Five weeks after antithyroid drug (ATD) was started, hyperthyroidism returned, coinciding with an increase of TRAb levels (> 40 U/L). Three additional exacerbations of hyperthyroidism occurred at weeks 28 (TRAb > 40 U/L), 32 (TRAb 36.4 U/L), and 36 (TRAb 26.2 U/L), despite close biochemical monitoring and adjustments of ATD. An uncomplicated spontaneous delivery of a healthy boy occurred at week 37. The neonate had normal weight, length, Apgar score, and was euthyroid (TSH 1.9 mIU/mL). He remained healthy and euthyroid at the last evaluation (9 months of age). This case is unusual because of several exacerbations of GD hyperthyroidism while on ATD during gestation, due to persistently high TRAb levels. Nevertheless, thanks to close maternal and fetal monitoring, neither maternal nor fetal complication occurred.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31:702–55.

    Article  CAS  Google Scholar 

  2. Nguyen CT, Sasso EB, Barton L, Mestman JH. Graves’ hyperthyroidism in pregnancy: a clinical review. Clin Diabetes Endocrinol. 2018;4:4.

    Article  Google Scholar 

  3. Cooper DS, Laurberg P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013;1:238–49.

    Article  CAS  Google Scholar 

  4. Falgarone G, Heshmati HM, Cohen R, Reach G. Mechanisms in endocrinology. Role of emotional stress in the pathophysiology of Graves’ disease. Eur J Endocrinol. 2012;168:R13–8.

    Article  Google Scholar 

  5. Vita R, Lapa D, Vita G, Trimarchi F, Benvenga S. A patient with stress-related onset and exacerbations of Graves disease. Nat Clin Pract Endocrinol Metab. 2009;5:55–61.

    Article  CAS  Google Scholar 

  6. Vita R, Lapa D, Trimarchi F, Benvenga S. Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves’ disease. Endocrine. 2015;48:254–63.

    Article  CAS  Google Scholar 

  7. Vita R, Lapa D, Trimarchi F, Vita G, Fallahi P, Antonelli A, et al. Certain HLA alleles are associated with stress-triggered Graves’ disease and influence its course. Endocrine. 2017;55:93–100.

    Article  CAS  Google Scholar 

  8. Weetman AP. Immunity, thyroid function and pregnancy: molecular mechanisms. Nat Rev Endocrinol. 2010;6:311–8.

    Article  CAS  Google Scholar 

  9. Patil-Sisodia K, Mestman JH. Graves hyperthyroidism and pregnancy: a clinical update. Endocr Pract. 2010;16:118–29.

    Article  Google Scholar 

  10. Delitala AP, Capobianco G, Cherchi PL, Dessole S, Delitala G. Thyroid function and thyroid disorders during pregnancy: a review and care pathway. Arch Gynecol Obstet. 2019;299:327–38.

    Article  CAS  Google Scholar 

  11. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27:315–89.

    Article  Google Scholar 

  12. Vita R, Mazzi V, Antonelli A, Benvenga S. Antithyroid medications and psychosis. Expert Opin Drug Saf. 2013;12:865–72.

    Article  CAS  Google Scholar 

  13. Andersen SL, Olsen J, Carle A, Laurberg P. Hyperthyroidism incidence fluctuates widely in and around pregnancy and is at variance with some other autoimmune diseases: a Danish population-based study. J Clin Endocrinol Metab. 2015;100:1164–71.

    Article  CAS  Google Scholar 

  14. Moleti M, Di Mauro M, Sturniolo G, Russo M, Vermiglio F. Hyperthyroidism in the pregnant woman: maternal and fetal aspects. J Clin Transl Endocrinol. 2019;16:100190.

    PubMed  PubMed Central  Google Scholar 

  15. Croce L, Di Dalmazi G, Orsolini F, Virili C, Brigante G, Gianetti E, et al. Graves’ disease and the post-partum period: an intriguing relationship. Front Endocrinol (Lausanne). 2019;10:853.

    Article  Google Scholar 

  16. Rotondi M, Capelli V, Coperchini F, Pinto S, Croce L, Tonacchera M, et al. Post-partum and non-post-partum relapsing Graves’ hyperthyroidism display different response to anti-thyroid drugs. Eur J Endocrinol. 2018;178:589–94.

    Article  CAS  Google Scholar 

  17. Fukao A, Takamatsu J, Murakami Y, Sakane S, Miyauchi A, Kuma K, et al. The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves’ disease. Clin Endocrinol. 2003;58:550–5.

    Article  Google Scholar 

  18. Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343–421.

    Article  Google Scholar 

  19. Huel C, Guibourdenche J, Vuillard E, Ouahba J, Piketty M, Oury JF, et al. Use of ultrasound to distinguish between fetal hyperthyroidism and hypothyroidism on discovery of a goiter. Ultrasound Obstet Gynecol. 2009;33:412–20.

    Article  CAS  Google Scholar 

  20. Laurberg P, Nygaard B, Glinoer D, Grussendorf M, Orgiazzi J. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol. 1998;139:584–6.

    Article  CAS  Google Scholar 

  21. Bucci I, Giuliani C, Napolitano G. Thyroid-stimulating hormone receptor antibodies in pregnancy: clinical relevance. Front Endocrinol (Lausanne). 2017;8:137.

    Article  Google Scholar 

  22. McLachlan SM, Rapoport B. Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid. 2013;23:14–24.

    Article  CAS  Google Scholar 

  23. Zakarija M, McKenzie JM, Munro DS. Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves’ disease. J Clin Invest. 1983;72:1352–6.

    Article  CAS  Google Scholar 

  24. Vita R, Di Bari F, Perelli S, Capodicasa G, Benvenga S. Thyroid vascularization is an important ultrasonographic parameter in untreated Graves’ disease patients. J Clin Translational Endocrinol. 2019;15:65–9.

    Article  Google Scholar 

  25. Pearce EN. Management of thyrotoxicosis: preconception, pregnancy, and the postpartum period. Endocr Pract. 2019;25:62–8.

    Article  Google Scholar 

  26. Oltmann SC, Brekke AV, Schneider DF, Schaefer SC, Chen H, Sippel RS. Preventing postoperative hypocalcemia in patients with Graves disease: a prospective study. Ann Surg Oncol. 2015;22:952–8.

    Article  Google Scholar 

  27. Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Torring O. TSH-receptor autoimmunity in Graves’ disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol. 2008;158:69–75.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Medicine, University of Messina, Viale Gazzi, 98125, Messina, Italy

    Flavia Di Bari, Sarah Perelli, Roberto Vita, Francesco Vermiglio, Salvatore Benvenga & Mariacarla Moleti

  2. Department of Human Pathology in Adulthood and Childhood Gaetano Barresi, University of Messina, Messina, Italy

    Angela Scilipoti & Malgorzata Wasniewska

  3. Master Program on Childhood, Adolescent and Women’s Endocrine Health, University of Messina, Messina, Italy

    Salvatore Benvenga

  4. Interdepartmental Program on Molecular & Clinical Endocrinology, and Women’s Endocrine Health, University hospital, A.O.U. Policlinico G. Martino, Messina, Italy

    Salvatore Benvenga

Authors
  1. Flavia Di Bari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarah Perelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angela Scilipoti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Malgorzata Wasniewska
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roberto Vita
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francesco Vermiglio
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Salvatore Benvenga
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mariacarla Moleti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto Vita.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Written informed consent was obtained from the patient for publication of this case report.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Medicine

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Di Bari, F., Perelli, S., Scilipoti, A. et al. Stress-Triggered Graves’ Disease with Multiple Exacerbations in a Pregnant Woman with High Levels of Thyrotropin Receptor Antibodies and No Complicated Delivery: a Case Report. SN Compr. Clin. Med. 2, 355–360 (2020). https://doi.org/10.1007/s42399-020-00247-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42399-020-00247-7

Keywords

Search

Navigation